Editorial commentary: Role of autonomic neuromodulation for the treatment of heart failure with reduced ejection fraction: The jury is still out

Trends Cardiovasc Med. 2024 Feb;34(2):108-109. doi: 10.1016/j.tcm.2022.10.003. Epub 2022 Oct 20.

Author

Affiliation

¹ Section of Cardiomyopathy & Heart Transplantation, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, United States; The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA, United States. Electronic address: selim.krim@ochsner.org.

PMID: 36272705
DOI: 10.1016/j.tcm.2022.10.003

No abstract available

Keywords: Baroreceptor activation therapy; Heart failure; Neuromodulation; Renal denervation; Spinal cord stimulation; Vagal nerve stimulation.

Publication types

Editorial

MeSH terms

Autonomic Nervous System
Heart Failure* / diagnosis
Heart Failure* / therapy
Humans
Vagus Nerve Stimulation*